Şahin Bodur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Şahin Bodur has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Ayhan Congologlu
Department of Child and Adolescent Psychiatry, University of Health Sciences, Gulhane Training and Research Hospital
5 shared publications - Ayhan Cöngöloğlu
SBÜ Gülhane Eğitim ve Araştırma Hastanesi
4 shared publications - Cansel Azizağaoğlu
SBÜ Gülhane Eğitim ve Araştırma Hastanesi
4 shared publications - Abdülbaki Artık
Child and Adolescent Psychiatry Department, Gulhane Training and Research Hospital University of Health Sciences Ankara Turkey
2 shared publications - Esra Doğan Elmas
UNIVERSITY OF HEALTH SCIENCES, GÜLHANE SCHOOL OF MEDICINE, GÜLHANE MEDICINE PR. (ANKARA)
2 shared publications - Halenur Teke
Child and Adolescent Psychiatry Department, Gulhane Training and Research Hospital University of Health Sciences Ankara Turkey
2 shared publications
Latest Publications
- Open Access
- 19 September 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (5) , 1370-1378
Serum 25-hydroxyvitamin D, vitamin B12, and folate concentrations in children with autism spectrum disorder: a case-control study from a tertiary care center in Turkiye
Aims: This study aimed to compare serum 25-hydroxyvitamin D [25(OH)D], vitamin B12, and folate concentrations between children with autism spectrum disorder (ASD) and typically developing controls, and to examine their relationship with autism symptom severity.Methods: This case-control study combined prospective clinical evaluation with retrospective retrieval of routine serum 25(OH)D, vitamin B12, and folate measurements from electronic medical records. The study included 140 children aged 2-8 years, comprising 70 children with ASD and 70 age- and gender-comparable typically developing controls, at a tertiary university hospital in Turkiye. ASD diagnosis was established according to DSM-5 criteria, and symptom severity was assessed using the Childhood Autism Rating Scale (CARS). Group comparisons, correlation analyses, and multivariable linear regression were performed.Results: Children with ASD had lower mean serum 25(OH)D concentrations than controls (mean difference: -3.43 ng/ml, 95% CI: -6.07 to -0.79; Cohen’s d=-0.43; p=0.011). Vitamin B12 and folate concentrations did not differ significantly between groups. The frequencies of vitamin D, vitamin B12, and folate deficiencies were also comparable between the ASD and control groups. Within the ASD group, none of the evaluated micronutrients differed by ASD severity or correlated with CARS scores. In the multivariable linear regression analysis, ASD group status and season of blood sampling remained independently associated with serum 25(OH)D concentrations after adjustment for age, gender, and body-mass index z-score.Conclusion: Children with ASD had lower mean serum 25(OH)D concentrations than typically developing controls, although vitamin D deficiency rates were comparable between the groups. This finding suggests that vitamin D status may warrant attention as a modifiable aspect of nutritional health in this population but should not be interpreted as an ASD-specific biomarker. Longitudinal and intervention-based studies are needed to clarify the directionality and clinical significance of this association and the potential benefit of supplementation in ASD.
- 19 September 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (5) , 1370-1378
Open AccessSerum 25-hydroxyvitamin D, vitamin B12, and folate concentrations in children with autism spectrum disorder: a case-control study from a tertiary care center in Turkiye
Aims: This study aimed to compare serum 25-hydroxyvitamin D [25(OH)D], vitamin B12, and folate concentrations between children with autism spectrum disorder (ASD) and typically developing controls, and to examine their relationship with autism symptom severity.Methods: This case-control study combined prospective clinical evaluation with retrospective retrieval of routine serum 25(OH)D, vitamin B12, and folate measurements from electronic medical records. The study included 140 children aged 2-8 years, comprising 70 children with ASD and 70 age- and gender-comparable typically developing controls, at a tertiary university hospital in Turkiye. ASD diagnosis was established according to DSM-5 criteria, and symptom severity was assessed using the Childhood Autism Rating Scale (CARS). Group comparisons, correlation analyses, and multivariable linear regression were performed.Results: Children with ASD had lower mean serum 25(OH)D concentrations than controls (mean difference: -3.43 ng/ml, 95% CI: -6.07 to -0.79; Cohen’s d=-0.43; p=0.011). Vitamin B12 and folate concentrations did not differ significantly between groups. The frequencies of vitamin D, vitamin B12, and folate deficiencies were also comparable between the ASD and control groups. Within the ASD group, none of the evaluated micronutrients differed by ASD severity or correlated with CARS scores. In the multivariable linear regression analysis, ASD group status and season of blood sampling remained independently associated with serum 25(OH)D concentrations after adjustment for age, gender, and body-mass index z-score.Conclusion: Children with ASD had lower mean serum 25(OH)D concentrations than typically developing controls, although vitamin D deficiency rates were comparable between the groups. This finding suggests that vitamin D status may warrant attention as a modifiable aspect of nutritional health in this population but should not be interpreted as an ASD-specific biomarker. Longitudinal and intervention-based studies are needed to clarify the directionality and clinical significance of this association and the potential benefit of supplementation in ASD.
- Open Access
- 21 August 2026
- Published by Türkiye Yeşilay Cemiyeti / Turkish Green Crescent Society in ADDICTA: The Turkish Journal on Addictions
- p. 1-10
Smartphone addiction and nomophobia in adolescents diagnosed with obsessive-compulsive disorder: A cross-sectional study
With the rapid rise in smartphone use among adolescents, issues such as smartphone addiction and nomophobia have become increasingly prevalent and clinically relevant. This study sought to examine differences in smartphone addiction and nomophobia between adolescents diagnosed with obsessive-compulsive disorder (OCD) and healthy controls, as well as to identify predictors of smartphone addiction in those with OCD. The sample consisted of 65 adolescents aged 12–18 years with OCD diagnosed according to DSM-5 criteria and 65 age- and sex-matched healthy controls. All participants underwent the K-SADS-PL interview, while the OCD group was additionally assessed using the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS). Both groups completed the Nomophobia Questionnaire, the Barratt Impulsiveness Scale–11 Short Form, and the Smartphone Addiction Scale–Short Version. The results indicated that adolescents with OCD had significantly higher levels of problematic smartphone use than healthy controls, although nomophobia scores did not differ significantly between groups. Regression analyses revealed non-planning impulsivity as a significant predictor of problematic smartphone use within the OCD group. These findings suggest that adolescents with OCD are more vulnerable to problematic smartphone use, potentially due to underlying impulsivity traits. Clinicians should consider impulsivity when evaluating and treating behavioral addictions in this population.
- 21 August 2026
- Published by Türkiye Yeşilay Cemiyeti / Turkish Green Crescent Society in ADDICTA: The Turkish Journal on Addictions
- p. 1-10
Open AccessSmartphone addiction and nomophobia in adolescents diagnosed with obsessive-compulsive disorder: A cross-sectional study
With the rapid rise in smartphone use among adolescents, issues such as smartphone addiction and nomophobia have become increasingly prevalent and clinically relevant. This study sought to examine differences in smartphone addiction and nomophobia between adolescents diagnosed with obsessive-compulsive disorder (OCD) and healthy controls, as well as to identify predictors of smartphone addiction in those with OCD. The sample consisted of 65 adolescents aged 12–18 years with OCD diagnosed according to DSM-5 criteria and 65 age- and sex-matched healthy controls. All participants underwent the K-SADS-PL interview, while the OCD group was additionally assessed using the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS). Both groups completed the Nomophobia Questionnaire, the Barratt Impulsiveness Scale–11 Short Form, and the Smartphone Addiction Scale–Short Version. The results indicated that adolescents with OCD had significantly higher levels of problematic smartphone use than healthy controls, although nomophobia scores did not differ significantly between groups. Regression analyses revealed non-planning impulsivity as a significant predictor of problematic smartphone use within the OCD group. These findings suggest that adolescents with OCD are more vulnerable to problematic smartphone use, potentially due to underlying impulsivity traits. Clinicians should consider impulsivity when evaluating and treating behavioral addictions in this population.
- 11 August 2026
- Published by Wolters Kluwer Health in American Journal of Therapeutics
Fecal Soiling Following Low-Dose Aripiprazole Treatment in a Child
Was not provided for this article.
- 11 August 2026
- Published by Wolters Kluwer Health in American Journal of Therapeutics
Fecal Soiling Following Low-Dose Aripiprazole Treatment in a Child
Was not provided for this article.
- Open Access
- 18 May 2026
- Published by Yildirim Beyazit University Yenimahalle Education and Research Hospital in Türk Tıp Dergisi
- Vol. 11 (2) , 73-78
Retinoblastom ve Otizm Spektrum Bozukluğu Eş Tanısı: Nadir Bir Pediatrik Vaka Sunumu
Otizm spektrum bozukluğu (OSB), sosyal iletişim ve etkileşimde yetersizlik, sınırlı ilgi alanları ve tekrarlayıcı davranışlarla karakterize görünümü olan nörogelişimsel bir bozukluktur ve son yıllarda sıklığı giderek artmaktadır. OSB’de yaygın olarak psikiyatrik komorbiditeler görülmekle birlikte görme işlevini potansiyel olarak etkileyebilecek oftalmolojik komorbiditeler açısından literatürde az sayıda veri mevcuttur. Mevcut veriler ve yapılan çalışmalar özellikle refraksiyon kusurları, şaşılık ve ambliyopi olmak üzere OSB’li çocuklarda oftalmolojik bozuklukların, yaklaşık %15 ile %52 arasında, artmış bir oranla görüldüğünü göstermektedir. Retinoblastom, çocukluk çağında en sık rastlanan intraoküler malign tümör olup RB1 geninde oluşan bir çeşit mutasyonla ilişkilidir. Bu hastalık erken dönemde belirti vermekte ve olguların çoğunun dört yaşından önce tanısı konmaktadır. Literatürde otizm ve retinoblastomun beraberliğinin bildirildiği çalışma sayısı oldukça azdır. Nadir görülmesine rağmen, retinoblastom ve OSB birlikteliğinin bazı vakalarda kromozomal anomalilere bağlı olarak ortaya çıkabileceği düşünülmektedir. Bu çalışmada, otizm spektrum bozukluğu tanısı bulunan ve retinoblastom saptanan bir pediatrik vaka sunulmaktadır. Nadir görülen bu birlikteliğin olası genetik tanısı ve klinik durumu değerlendirilirken aynı zamanda OSB’li çocuklardaki görme işlevinin önemi vurgulanmaktadır. Görme işlevindeki yetersizliğin, sosyal iletişim becerileri açısından olumsuz sonuçlar yaratabileceği, özel eğitim desteğinden yeterince faydalanmasını engelleyeceği düşüncesiyle sadece retinoblastom değil, diğer tüm oftalmolojik problemlerin erken dönemde tanısının ve tedavisinin otizm spektrum bozukluğuna sahip çocuklarda çevresel uyaranları anlama ve algılama açısından olumlu bir etkiye sahip olacağını düşünmekteyiz.
- 18 May 2026
- Published by Yildirim Beyazit University Yenimahalle Education and Research Hospital in Türk Tıp Dergisi
- Vol. 11 (2) , 73-78
Open AccessRetinoblastom ve Otizm Spektrum Bozukluğu Eş Tanısı: Nadir Bir Pediatrik Vaka Sunumu
Otizm spektrum bozukluğu (OSB), sosyal iletişim ve etkileşimde yetersizlik, sınırlı ilgi alanları ve tekrarlayıcı davranışlarla karakterize görünümü olan nörogelişimsel bir bozukluktur ve son yıllarda sıklığı giderek artmaktadır. OSB’de yaygın olarak psikiyatrik komorbiditeler görülmekle birlikte görme işlevini potansiyel olarak etkileyebilecek oftalmolojik komorbiditeler açısından literatürde az sayıda veri mevcuttur. Mevcut veriler ve yapılan çalışmalar özellikle refraksiyon kusurları, şaşılık ve ambliyopi olmak üzere OSB’li çocuklarda oftalmolojik bozuklukların, yaklaşık %15 ile %52 arasında, artmış bir oranla görüldüğünü göstermektedir. Retinoblastom, çocukluk çağında en sık rastlanan intraoküler malign tümör olup RB1 geninde oluşan bir çeşit mutasyonla ilişkilidir. Bu hastalık erken dönemde belirti vermekte ve olguların çoğunun dört yaşından önce tanısı konmaktadır. Literatürde otizm ve retinoblastomun beraberliğinin bildirildiği çalışma sayısı oldukça azdır. Nadir görülmesine rağmen, retinoblastom ve OSB birlikteliğinin bazı vakalarda kromozomal anomalilere bağlı olarak ortaya çıkabileceği düşünülmektedir. Bu çalışmada, otizm spektrum bozukluğu tanısı bulunan ve retinoblastom saptanan bir pediatrik vaka sunulmaktadır. Nadir görülen bu birlikteliğin olası genetik tanısı ve klinik durumu değerlendirilirken aynı zamanda OSB’li çocuklardaki görme işlevinin önemi vurgulanmaktadır. Görme işlevindeki yetersizliğin, sosyal iletişim becerileri açısından olumsuz sonuçlar yaratabileceği, özel eğitim desteğinden yeterince faydalanmasını engelleyeceği düşüncesiyle sadece retinoblastom değil, diğer tüm oftalmolojik problemlerin erken dönemde tanısının ve tedavisinin otizm spektrum bozukluğuna sahip çocuklarda çevresel uyaranları anlama ve algılama açısından olumlu bir etkiye sahip olacağını düşünmekteyiz.
- Open Access
- 30 April 2026
- Published by T.C. Sağlık Bakanlığı Ankara Atatürk Sanatoryum Eğitim ve Araştırma Hastanesi in Sanatorium Medical Journal
- Vol. 2 (2) , 98-100
Risperidone Induced Tardive Dyskinesia In An Adolescent With Intellectual Disability
Risperidone is an effective antipsychotic commonly used for behavioral problems in children with intellectual disability. Several studies confirm its effectiveness for up to one year, but long-term use is associated with adverse effects such as dyskinesia, akathisia, and parkinsonism. Furthermore, risperidone can cause tardive dyskinesia (TD) in certain patients, especially children with intellectual disability who are more likely to experience side effects of antipsychotics.
- 30 April 2026
- Published by T.C. Sağlık Bakanlığı Ankara Atatürk Sanatoryum Eğitim ve Araştırma Hastanesi in Sanatorium Medical Journal
- Vol. 2 (2) , 98-100
Open AccessRisperidone Induced Tardive Dyskinesia In An Adolescent With Intellectual Disability
Risperidone is an effective antipsychotic commonly used for behavioral problems in children with intellectual disability. Several studies confirm its effectiveness for up to one year, but long-term use is associated with adverse effects such as dyskinesia, akathisia, and parkinsonism. Furthermore, risperidone can cause tardive dyskinesia (TD) in certain patients, especially children with intellectual disability who are more likely to experience side effects of antipsychotics.
- Open Access
- 25 February 2026
- Published by Yildirim Beyazit University Yenimahalle Education and Research Hospital in Türk Tıp Dergisi
- Vol. 11 (1) , 24-30
DDX3X Sendromu ve Eşlik Eden Otizm Spektrum Bozukluğu Olan Kız Çocuk: Bir Olgu Sunumu
DDX3X sendromu, X kromozomuna bağlı DDX3X genindeki mutasyonlardan kaynaklanan, gelişimsel gecikme, entelektüel yetersizlik, konuşma-dil gecikmeleri veya bozuklukları, otizm spektrum bozukluğu (OSB) ve dikkat eksikliği ve hiperaktivite bozukluğu (DEHB) gibi nörogelişimsel bozuklukların sıklıkla eşlik ettiği bir genetik hastalıktır. DDX3X sendromu nadir görülen bir genetik hastalıktır ve literatürde bildirilen vakaların sayısı azdır. Hakkında yeterli bilgi sahibi olunamaması ve DDX3X sendromunun OSB ile benzer özellikler taşıyabilmesi sebebiyle, DDX3X sendromuna eşlik eden OSB tanısının ayırt edilmesi her zaman mümkün olamamaktadır. Kliniğimizde muayene edilen, DDX3X sendromlu hafif düzeyde entelektüel yetersizlik, dikkat eksikliği ve hiperaktivite bozukluğu, konuşma bozukluğu tanıları olan dokuz yaşında bir kız hastaya geç dönemde otizm tanısı konulmuştur. Bu hastalarda doğru ve etkili tedavi yaklaşımlarının uygulanabilmesi için erken dönemde tanı konulmasına katkı sağlamak amacıyla ve literatüre katkı sağlaması amacıyla bu olgu sunumu hazırlanmıştır.
- 25 February 2026
- Published by Yildirim Beyazit University Yenimahalle Education and Research Hospital in Türk Tıp Dergisi
- Vol. 11 (1) , 24-30
Open AccessDDX3X Sendromu ve Eşlik Eden Otizm Spektrum Bozukluğu Olan Kız Çocuk: Bir Olgu Sunumu
DDX3X sendromu, X kromozomuna bağlı DDX3X genindeki mutasyonlardan kaynaklanan, gelişimsel gecikme, entelektüel yetersizlik, konuşma-dil gecikmeleri veya bozuklukları, otizm spektrum bozukluğu (OSB) ve dikkat eksikliği ve hiperaktivite bozukluğu (DEHB) gibi nörogelişimsel bozuklukların sıklıkla eşlik ettiği bir genetik hastalıktır. DDX3X sendromu nadir görülen bir genetik hastalıktır ve literatürde bildirilen vakaların sayısı azdır. Hakkında yeterli bilgi sahibi olunamaması ve DDX3X sendromunun OSB ile benzer özellikler taşıyabilmesi sebebiyle, DDX3X sendromuna eşlik eden OSB tanısının ayırt edilmesi her zaman mümkün olamamaktadır. Kliniğimizde muayene edilen, DDX3X sendromlu hafif düzeyde entelektüel yetersizlik, dikkat eksikliği ve hiperaktivite bozukluğu, konuşma bozukluğu tanıları olan dokuz yaşında bir kız hastaya geç dönemde otizm tanısı konulmuştur. Bu hastalarda doğru ve etkili tedavi yaklaşımlarının uygulanabilmesi için erken dönemde tanı konulmasına katkı sağlamak amacıyla ve literatüre katkı sağlaması amacıyla bu olgu sunumu hazırlanmıştır.
- 2 February 2026
- Published by Taylor & Francis in International Journal of Developmental Disabilities
- Vol. 72 (3) , 609-621
Anti-thyroid peroxidase antibodies in autism spectrum disorder: a marker of subclinical autoimmune activity in children
- 2 February 2026
- Published by Taylor & Francis in International Journal of Developmental Disabilities
- Vol. 72 (3) , 609-621
Anti-thyroid peroxidase antibodies in autism spectrum disorder: a marker of subclinical autoimmune activity in children
- Open Access
- 1 January 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- No. Early Acce
Fluoxetine-Induced Dyskinesia in a Pediatric Patient: A Case Report and Literature Review on Implications of Polypharmacy and Serotonergic Regulation
Movement disorders associated with psychiatric medications are primarily related to the side effects of dopamine receptor-blocking drugs, which are mostly antipsychotic medications. These side effects are acute dystonic reactions, akathisia, dyskinesia, neuroleptic malignant syndrome, parkinsonism, and various tardive syndromes. Dyskinetic movements are characterized by hyperkinetic, repetitive movements of the extremities, facial, and perioral muscles. In rare cases, dyskinetic movements may occur with the use of selective serotonin reuptake inhibitors (SSRIs) through an indirect D2 blocking mechanism. In this case report, dyskinesia observed after increasing the dose of fluoxetine in a patient using methylphenidate and risperidone was presented. It was thought that the SSRI inhibited dopamine activity through dopamine receptor antagonism and that SSRIs may increase risperidone concentrations by inhibiting CYP450 metabolism. There are few cases reported in the literature regarding SSRI-induced dyskinesia, information is limited on this subject. This case report highlights the potential dyskinesia side effect of SSRIs.
- 1 January 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- No. Early Acce
Open AccessFluoxetine-Induced Dyskinesia in a Pediatric Patient: A Case Report and Literature Review on Implications of Polypharmacy and Serotonergic Regulation
Movement disorders associated with psychiatric medications are primarily related to the side effects of dopamine receptor-blocking drugs, which are mostly antipsychotic medications. These side effects are acute dystonic reactions, akathisia, dyskinesia, neuroleptic malignant syndrome, parkinsonism, and various tardive syndromes. Dyskinetic movements are characterized by hyperkinetic, repetitive movements of the extremities, facial, and perioral muscles. In rare cases, dyskinetic movements may occur with the use of selective serotonin reuptake inhibitors (SSRIs) through an indirect D2 blocking mechanism. In this case report, dyskinesia observed after increasing the dose of fluoxetine in a patient using methylphenidate and risperidone was presented. It was thought that the SSRI inhibited dopamine activity through dopamine receptor antagonism and that SSRIs may increase risperidone concentrations by inhibiting CYP450 metabolism. There are few cases reported in the literature regarding SSRI-induced dyskinesia, information is limited on this subject. This case report highlights the potential dyskinesia side effect of SSRIs.
- 26 October 2022
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 45 (6) , 184-186
Dose-Dependent Enuresis in Methylphenidate Use
Objectives: Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood. Although enuresis is a very common disorder in child diagnosed with ADHD, it may also develop because of methylphenidate. Methods: Authors report here on a child case of ADHD that developed a probable enuresis related to methylphenidate. Results and Conclusions: Clinicians should be aware that methylphenidate used in ADHD causes dose-dependent enuresis.
- 26 October 2022
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 45 (6) , 184-186
Dose-Dependent Enuresis in Methylphenidate Use
Objectives: Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood. Although enuresis is a very common disorder in child diagnosed with ADHD, it may also develop because of methylphenidate. Methods: Authors report here on a child case of ADHD that developed a probable enuresis related to methylphenidate. Results and Conclusions: Clinicians should be aware that methylphenidate used in ADHD causes dose-dependent enuresis.
- Open Access
- 30 August 2022
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 24 (2) , 212-214
17-year-old Selective Mutism Case without Treatment for A Long Time
Selective mutism is a rare childhood anxiety disorder characterized by the inability to speak in certain social situations in which speech is expected, despite speaking fluently in other situations. The average age of onset for selective mutism is 2 to 5 years old, but symptoms may not be noticed until starting school. The cause is still not known and the prevalence varies between 0.03% and 1%. Psychopharmacology and psychotherapeutic approaches are recommended in the treatment. Although the treatment is difficult, early diagnosis is one of the good prognostic factors. In this case report, we aimed to discuss the psychiatric and sociocultural functionality of a 17-year-old adolescent with selective mutism. Our case is remarkable as she has not been treated for many years. Her treatment continues with psychopharmacological and psychotherapeutic interventions. Recognition of selective mutism and getting support on this issue will help to solve the problem.
- 30 August 2022
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 24 (2) , 212-214
Open Access17-year-old Selective Mutism Case without Treatment for A Long Time
Selective mutism is a rare childhood anxiety disorder characterized by the inability to speak in certain social situations in which speech is expected, despite speaking fluently in other situations. The average age of onset for selective mutism is 2 to 5 years old, but symptoms may not be noticed until starting school. The cause is still not known and the prevalence varies between 0.03% and 1%. Psychopharmacology and psychotherapeutic approaches are recommended in the treatment. Although the treatment is difficult, early diagnosis is one of the good prognostic factors. In this case report, we aimed to discuss the psychiatric and sociocultural functionality of a 17-year-old adolescent with selective mutism. Our case is remarkable as she has not been treated for many years. Her treatment continues with psychopharmacological and psychotherapeutic interventions. Recognition of selective mutism and getting support on this issue will help to solve the problem.